搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
SBS
2 年
COVID-19的潜在“解药”将在墨尔本进入临床试验
抗艾滋病药物洛匹那韦/利托那韦(Lopinavir/Ritonavir)和治疗疟疾的羟氯喹(hydroxychloroquine)将在皇家墨尔本医院用于临床试验 ...
SBS
2 年
ATAGI:12至15岁青少年无需接种加强针
与此同时,另一处监管机构已建议将新冠药物奈玛特韦(nirmatrelvir)和利托那韦(ritonavir)列入PBS清单。 前者是一种口服治疗药物,通过抑制SARS-CoV ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Shot multiple times in Vegas
Gets minimum 28 years
Campaign denies plagiarism
Trump Media stock plunges
Revives Fox News lawsuit
Grants honorable discharges
SCOTUS rejects appeal
Ownership stake approved
Salton Sea conservation
US Navy aircraft crashes
Testifies before Congress
Cereal dyes protested
Felon voting rights upheld
To return to Atlanta in 2028
Had benign cyst removed
GA hand-count rule blocked
US adults loneliness survey
MI shooter drill settlement
Exotic cat caught in suburb
SpaceX sues CA regulators
To invest in nuclear reactors
PA gun restrictions ruling
Parents sue MA school
$1.4B renovation deal OK'd
Out of disaster loan money
Ordered to pay $15 million
$750M US chips grant
Broadband data caps probe
'Click to cancel' finalized
Must face US state lawsuits
反馈